David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Medicine and Philosophy 7 (4):355-374 (1982)
As rapid advances in human genetic research are transferred into new areas of genetic technology, questions relatingto the use of these techniques will escalate. This paper examines some of the policy concerns surrounding recent developments in genetic screening. It discusses the impetus and implications of genetic screening in general, examines various applications, and analyzes the costs and benefits of screening programs currently in existence. Special emphasis is placed on whether or not screening should be considered a matter of public health and mandated on those grounds. This paper argues against any compulsory screening programs except where the disease is easily identified, applicable across social groups, and treatable. While screening services for carriers of genetic disease and prenatal diagnosis should be made available and education programs should be expanded substantially, the burden of proof for involuntary programs is placed on the proponents. There is little public health justification at thb time for mandatory screening though this does not preclude future public health demands. It is argued that the goals and justification of various human genetic technologies must be examined at this time due to the rapid advancement of the research as well as the ultimate benefits promised for humankind. CiteULike Connotea Del.icio.us What's this?
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Claudia Wild (2008). Polymorphism-Screening: Genetic Testing for Predisposition—Guidance for Technology Assessment. [REVIEW] Poiesis and Praxis 5 (1):1-14.
Burke K. Zimmerman (1991). Human Germ-Line Therapy: The Case for its Development and Use. Journal of Medicine and Philosophy 16 (6):593-612.
Jose Sanmart�N. (1995). The New World of Human Genetic Technologies: The Policy Environment and Impacts of Genetic Screening Tests. [REVIEW] AI and Society 9 (1):105-114.
Kurt Bayertz (1998). What's Special About Molecular Genetic Diagnostics? Journal of Medicine and Philosophy 23 (3):247 – 254.
Alan Strudler (1994). The Social Construction of Genetic Abnormality: Ethical Implications for Managerial Decisions in the Workplace. [REVIEW] Journal of Business Ethics 13 (11):839 - 848.
Ayodele S. Jegede (2009). Culture and Genetic Screening in Africa. Developing World Bioethics 9 (3):128-137.
Diane B. Paul (1994). Toward a Realistic Assessment of PKU Screening. PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1994:322 - 328.
Jyotsna Agnihotri Gupta (2007). Private and Public Eugenics: Genetic Testing and Screening in India. [REVIEW] Journal of Bioethical Inquiry 4 (3):217-228.
Joseph Kupfer (1993). The Ethics of Genetic Screening in the Workplace. Business Ethics Quarterly 3 (1):17-25.
Ruth Chadwick, Henk ten Have, Jfrgen Husted, Mairi Levitt, Tony McGleenan, Darren Shickle & Urban Wiesing (1998). Genetic Screening and Ethics: European Perspectives. Journal of Medicine and Philosophy 23 (3):255 – 273.
Added to index2010-08-14
Total downloads9 ( #155,891 of 1,099,037 )
Recent downloads (6 months)2 ( #175,277 of 1,099,037 )
How can I increase my downloads?